We recently identified 1alpha,25-dihydroxy 3 epi-vitamin D3 (1alpha,25(OH)2-3-epi-D3) as a major metabolite of 1alpha,25- dihydroxy vitamin D3 (1alpha,25(OH)2D3) in the primary cultures of human keratinocytes. It is noted that the production of 1alpha,25(OH)2-3-epi-D3 is tissue specific. Also, 1alpha,25(OH)2-3-epi-D3 when compared to 1alph,25(OH)2D3 was found to be less active in generating some of the classical 1alpha,25(OH)2D3 mediated genomic biological responses. These biological activity findings indicated that the metabolism of 1alpha,25(OH)2D3 into 1alpha,25(OH)2-3-epi-D3 in target tissues leads to significant reduction in the activity of 1alpha,25(OH)2D3. Furthermore, we also identified 1alpha,25(OH)2-3-epi-D3 as a circulating metabolite in rats treated with pharmacological amounts of either 1alpha(OH)D3 or 1alpha,25(OH)2D3. Thus, this newly discovered metabolic pathway of 1alpha,25(OH)2D3 like the previously well established C-24 oxidation pathway, appears to play a significant role in the target tissue inactivation of 1alpha,25(OH)2D3. In the present grant proposal we coined the term """"""""3beta-hydroxy epimerase"""""""", for the enzyme(s) responsible for epimerization of 3beta-hydroxyl of 1alha,25(OH)2D3. The following studies are proposed to elucidate the overall functional significance of our novel observation of the tissue specific metabolism of 1alpha,25(OH)2D3 into 1alpha,25(OH)2-3-epi-D3 in the vitamin D-endocrine system. 1) further investigations towards establishing the target tissue specificity for the production of 1alpha,25(OH)2-3-epi-D3 in normal tissues from human, rat and chick species; 2) subcellular localization and enzyme kinetic studies to characterize the enzyme(s) responsible for the production of 1alpha,25(OH)2-3- epi-D3; 3) studies of further target tissue metabolism of 1alpha,25(OH)2-3-epi-D3; 4) comparative pharmacokinetic and biological activity studies between 1alpha,25(OH)2D3 and the newly discovered metabolite 1alpha,25(O2H)-3-epi-3-D. 5) studies of 1alpha,25(OH)2-3-epi-D3 production in mice that lack 24-hydroxylase to identify the 3beta-hydroxy epimerization as the possible alternate pathway for the inactivation of 1alpha,25(OH)2D3. It is anticipated that knowledge of target tissue specific metabolism of 1alpha,25(OH)2D3 will provide important information for our improved understanding of how 1alpha,25(OH)2D3 is inactivated in various different target tissue.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052488-03
Application #
6381331
Study Section
General Medicine B Study Section (GMB)
Program Officer
Margolis, Ronald N
Project Start
1999-06-15
Project End
2003-04-30
Budget Start
2001-05-01
Budget End
2002-04-30
Support Year
3
Fiscal Year
2001
Total Cost
$226,998
Indirect Cost
Name
Women and Infants Hospital-Rhode Island
Department
Type
DUNS #
069851913
City
Providence
State
RI
Country
United States
Zip Code
02905
Rhieu, Steve Y; Annalora, Andrew J; Wang, Guochun et al. (2013) Metabolic stability of 3-epi-1?,25-dihydroxyvitamin D3 over 1 ? 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1. J Cell Biochem 114:2293-305
Reddy, G Satyanarayana; Robinson, Matthew; Wang, Guochun et al. (2007) Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly. Arch Biochem Biophys 460:254-61
Reddy, G Satyanarayana; Omdahl, John L; Robinson, Matthew et al. (2006) 23-carboxy-24,25,26,27-tetranorvitamin D3 (calcioic acid) and 24-carboxy-25,26,27-trinorvitamin D3 (cholacalcioic acid): end products of 25-hydroxyvitamin D3 metabolism in rat kidney through C-24 oxidation pathway. Arch Biochem Biophys 455:18-30
Brown, Alex J; Ritter, Cynthia S; Weiskopf, A S et al. (2005) Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion. J Cell Biochem 96:569-78
Astecker, Norbert; Bobrovnikova, Ekaterina A; Omdahl, John L et al. (2004) C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1. Arch Biochem Biophys 431:261-70
Rehan, Virender K; Torday, John S; Peleg, Sara et al. (2002) 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells. Mol Genet Metab 76:46-56
Sunita Rao, Devara; Siu-Caldera, Mei-Ling; Sekimoto, Hiroko et al. (2002) Metabolism of 2-methyl analogs of 1alpha,25-dihydroxyvitamin D3 in rat osteosarcoma cells (UMR 106). Biol Pharm Bull 25:845-52
Reddy, G S; Muralidharan, K R; Okamura, W H et al. (2001) Metabolism of 1alpha,25-dihydroxyvitamin D(3) and its C-3 epimer 1alpha,25-dihydroxy-3-epi-vitamin D(3) in neonatal human keratinocytes. Steroids 66:441-50
Rao, D S; Campbell, M J; Koeffler, H P et al. (2001) Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL-60 cells. Steroids 66:423-31
Sunita Rao, D; Balkundi, D; Uskokovic, M R et al. (2001) Double bond in the side chain of 1alpha,25-dihydroxy-22-ene-vitamin D(3) is reduced during its metabolism: studies in chronic myeloid leukemia (RWLeu-4) cells and rat kidney. J Steroid Biochem Mol Biol 78:167-76

Showing the most recent 10 out of 14 publications